GE HealthCare Technologies Inc.
Company Stats
- Market Cap
- $29.5B
- as of Sep 30, 2026
- Enterprise Value
- $35.1B
- Shares Outstanding
- 451.7M
- Free Float
- 99.7%
Income Statement
- Revenue
- $20.6B
- Operating Income
- $2.8B
- Net Income
- $2.1B
- EBITDA
- $3.0B
- Revenue Growth, 3Y
- 4.0%
- FCF Margin, 3Y Avg
- 8.0%
- FCF Margin, Worst Year
- 7.3%
Cash Flow
- Free Cash Flow
- $1.5B
- FCF Yield
- 5.1%
- Owner FCF Yield
- 4.7%
Balance Sheet
- Cash & Equivalents
- $4.5B
- Total Debt
- $10.0B
- Net Debt
- $5.5B
- Net Debt / EBITDA
- 1.81x
- EV / EBITDA
- 11.49x
- Net Debt / EBIT
- 2.00x
Returns & Capital
- Dividends Paid
- $64.0M
- Dividend Yield
- 0.2%
- Dividend Payout, 3Y Avg
- 2.8%
- Share Repurchases
- $200.0M
- Buyback Yield, 3Y Avg
- 0.2%
- SBC, 3Y Avg
- $123.0M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $20.6B | $1.5B | 7.3% |
| FY2024 | $19.7B | $1.6B | 7.9% |
| FY2023 | $19.6B | $1.7B | 8.8% |
| FY2022 | $18.3B | $1.8B | 9.9% |
| FY2021 | $17.6B | $1.4B | 7.7% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 6, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.